Moleculin Biotech (MBRX) Capital Expenditures (2016 - 2024)
Moleculin Biotech (MBRX) reported Capital Expenditures of $13,000 for FY2024, down 89.5% from $124,000 in FY2023.
Powered by 
Analysis
Moleculin Biotech (MBRX) Capital Expenditures (2016 - 2024) Analysis & Trends
Dating back to FY2016, Moleculin Biotech's Capital Expenditures record includes 9 years.
- Capital Expenditures has a five-year compound annual growth rate of -24.2% (FY2019 to FY2024).
- The FY2024 figure ranks as the lowest annual Capital Expenditures in data going back to FY2016.
- According to Business Quant data, Capital Expenditures came in at $124,000 in FY2023 (+85.1%), $67,000 in FY2022 (+252.6%), $19,000 in FY2021 (-94.9%) and $376,000 in FY2020 (+623.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.71 Bn | 1,105.29 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.55 Bn | 536.07 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 501.02 Bn | 474.13 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 368.18 Bn | 322.56 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.89 Bn | 261.88 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.60 Bn | 191.99 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.77 Bn | 116.42 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Moleculin Biotech | 36.58 Mn | 6.18 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 13,000.00 |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | 28,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2022 | 61,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 16,000.00 |
| Sep 30, 2020 | 340,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 10,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 19,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | 114,000.00 |
| Sep 30, 2018 | 295,000.00 |
| Mar 31, 2018 | 8,000.00 |
| Dec 31, 2017 | 16,000.00 |
| Sep 30, 2017 | 8,000.00 |
API Access
Moleculin Biotech Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();